Aclaris Therapeutics, Inc. · NASDAQ:ACRS

BML Investment Partners, L.P. reported a 9.90% stake in Aclaris Therapeutics, Inc. (Schedule 13G/A)

Event Apr 23, 2026 · Filed Apr 27, 2026

BML Investment Partners, L.P. reported a 9.90% stake in Aclaris Therapeutics, Inc., 13,950,000 shares, as a passive investor on Apr 23, 2026. Filed Apr 27, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
13,950,000
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BML Investment Partners, L.P.9.90%13,950,000

Source

View original at SEC

Related